Search / Trial NCT06230328

Brazilian Reality of Hepatocellular Carcinoma

Launched by ASTRAZENECA · Jan 19, 2024

Trial Information

Current as of December 22, 2024

Completed

Keywords

Hepatocellular Carcinoma; Rwe

ClinConnect Summary

The clinical trial titled "Brazilian Reality of Hepatocellular Carcinoma" is studying liver cancer, specifically a type called hepatocellular carcinoma. Researchers want to understand how common this cancer is, how it is treated, how it progresses, and how long patients live after being diagnosed. They are looking at data from patients treated at specialized cancer care centers across Brazil over the past six years, from 2017 to 2022.

To participate in this trial, you need to be at least 18 years old and have a confirmed diagnosis of hepatocellular carcinoma, which can be shown through a biopsy or medical imaging. The trial is open to everyone, regardless of gender. However, if you have other specific types of liver tumors or have only visited a participating healthcare center once without follow-up, you would not be eligible to join. If you qualify, you can expect to provide information about your health and treatment history, which will help researchers gather important insights into the management of this disease in Brazil.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male and female;
  • Above 18 years old;
  • Hepatocellular carcinoma diagnosis (confirmed by biopsy or imaging);
  • Exclusion Criteria:
  • Fibrollamelar carcinoma, hepatoblastoma, intrahepatic cholangiocarcinoma, neuroendocrine tumors or other less common types of liver tumors;
  • Patients with incomplete staging data;
  • Patients with only 1 visit to the participating site healthcare service, with loss to follow-up prior to the second visit to the participating site healthcare service;
  • Previous treatment for hepatocellular carcinoma in another institution;
  • Treatment with investigational drugs in a clinical trial.

Trial Officials

Diogo Bugano

Principal Investigator

Hospital Israelita Albert Einstein

About Astrazeneca

AstraZeneca is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines across various therapeutic areas, including oncology, cardiovascular, respiratory, and autoimmune diseases. With a strong commitment to scientific research and patient-centric solutions, AstraZeneca leverages cutting-edge technology and a robust pipeline to address unmet medical needs. The company collaborates with healthcare professionals, academic institutions, and other organizations to advance clinical trials and deliver transformative therapies, aiming to improve health outcomes and enhance the quality of life for patients worldwide.

Locations

Belo Horizonte, , Brazil

Curitiba, , Brazil

Porto Alegre, , Brazil

Rio De Janeiro, , Brazil

Sao Paulo, , Brazil

Barretos, , Brazil

Florianopolis, , Brazil

Salvador, , Brazil

Recife, , Brazil

Sao Jose Do Rio Preto, , Brazil

Porto Alegre, Rio Grande Do Sul, Brazil

Porto Alegre, Rio Grande Do Sul, Brazil

Porto Alegre, Rio Grande Do Sul, Brazil

São Paulo, , Brazil

Natal, , Brazil

Vitoria, , Brazil

Natal, Rio Grande Do Norte, Brazil

Rio De Janeiro, , Brazil

Recife, Pernambuco, Brazil

Belo Horizonte, Minas Gerais, Brazil

Salvador, Bahia, Brazil

Vitória, Espirito Santo, Brazil

Florianópolis, Santa Catarina, Brazil

Barretos, São Paulo, Brazil

São Paulo, , Brazil

Belo Horizonte, Minas Gerais, Brazil

São José Do Rio Preto, São Paulo, Brazil

São Paulo, , Brazil

São Paulo, , Brazil

São Paulo, , Brazil

Sao Bernardo Do Campo, , Brazil

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0